Amir Reichman
Vorstandsvorsitzender bei SCINAI IMMUNOTHERAPEUTICS LTD.
Vermögen: 90 048 $ am 31.05.2024
Profil
Amir Reichman is the founder of NeuroDerm Ltd.
which was founded in 2003.
He was the Chief Engineer & Senior Scientist from 2003 to 2009.
Currently, he is the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd.
since 2021.
Previously, he worked at GlaxoSmithKline Pharmaceuticals SA (Belgium) as the Head-Global Vaccines Engineering Core Technology from 2015 to 2021 and at Novartis Vaccines & Diagnostics, Inc. (North Carolina) as the Head-Global Vaccines Value Chain Management from 2011 to 2015.
Mr. Reichman completed his undergraduate degree from Ben-Gurion University of the Negev and his MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.04.2024 | 9 600 000 ( 1,28% ) | 90 048 $ | 31.05.2024 |
Aktive Positionen von Amir Reichman
| Unternehmen | Position | Beginn |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Vorstandsvorsitzender | 02.03.2021 |
Ehemalige bekannte Positionen von Amir Reichman
| Unternehmen | Position | Ende |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | 01.03.2021 |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01.01.2015 |
| NEURODERM LTD | Gründer | 01.01.2009 |
Ausbildung von Amir Reichman
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Ben-Gurion University of the Negev | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
